Julien Kirchgesner
0000-0002-2314-9284
AP-HP, Hôpital Saint-Antoine
7 papers found
Refreshing results…
A methodological review of the high-dimensional propensity score in comparative-effectiveness and safety-of-interventions research finds incomplete reporting relative to algorithm development and robustness
Risk of Recurrent Acute Arterial Events Associated With Thiopurines and Anti-Tumor Necrosis Factor in Inflammatory Bowel Diseases
Rewiring the altered tryptophan metabolism as a novel therapeutic strategy in inflammatory bowel diseases
Decreased risk of treatment failure with vedolizumab and thiopurines combined compared with vedolizumab monotherapy in Crohn’s disease
Risk of acute arterial events associated with treatment of inflammatory bowel diseases: a nationwide Danish cohort study
Emulation of a randomized controlled trial in ulcerative colitis with US and French claims data: Infliximab with thiopurines compared to infliximab monotherapy
Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases
Missing publications? Search for publications with a matching author name.